189 related articles for article (PubMed ID: 36298603)
1. Long-Term Dynamic Humoral Response to SARS-CoV-2 mRNA Vaccines in Patients on Peritoneal Dialysis.
Quiroga B; Soler MJ; Ortiz A; Gansevoort RT; Leyva A; Rojas J; de Sequera P;
Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298603
[TBL] [Abstract][Full Text] [Related]
2. Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study.
Quiroga B; Soler MJ; Ortiz A; Jarava Mantecón CJ; Gomes Pérez VO; Bordils A; Lacueva J; Marin Franco AJ; Delgado Conde P; Muñoz Ramos P; Calderón González C; Cazorla López JM; Sanchez-Rodriguez J; Sánchez Horrillo A; Monzón Vázquez TR; Leyva A; Rojas J; Gansevoort RT; de Sequera P;
Nephrol Dial Transplant; 2023 Mar; 38(4):969-981. PubMed ID: 36423334
[TBL] [Abstract][Full Text] [Related]
3. Dialysis modality, humoral response to vaccine, and SARS-CoV-2 infection risk: Comparative prospective evaluation.
Bnaya A; Nacasch N; Einbinder Y; Shavit L; Erez D; Shashar M; Grupper A; Benchetrit S; Wand O; Cohen-Hagai K
Semin Dial; 2023; 36(5):382-389. PubMed ID: 37042666
[TBL] [Abstract][Full Text] [Related]
4. Waning of SARS-CoV-2 Vaccine-Induced Immune Response over 6 Months in Peritoneal Dialysis Patients and the Role of a Booster Dose in Maintaining Seropositivity.
Murt A; Dinc HO; Altiparmak MR; Yalin SF; Yadigar S; Parmaksiz E; Kocazeybek B; Pekpak M; Ataman MR
Nephron; 2022; 146(6):559-563. PubMed ID: 35598596
[TBL] [Abstract][Full Text] [Related]
5. Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study.
Quiroga B; Soler MJ; Ortiz A; Jaravaca Mantecón CJ; Nava Pérez N; Serra Martín M; Sato Y; Marin Franco AJ; Pazmiño Zambrano DF; Lucena Valverde R; Ortega Diaz M; Calderón González C; Cazorla López JM; Pereira M; González Parra E; Sánchez Horrillo A; Sánchez González C; Toapanta N; Cigarrán Guldris S; Sánchez Hernández R; Pizarro Sánchez S; Muñiz Rincón M; Garcia-Fernández N; Blanco Castro N; Collantes Mateo R; Quiroz Morales MA; Escamilla-Cabrera B; Berdud Godoy I; Gil-Casares Casanova B; Leyva A; Rojas J; Gansevoort RT; de Sequera P;
Clin Kidney J; 2022 Oct; 15(10):1856-1864. PubMed ID: 36147708
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
Front Immunol; 2022; 13():863554. PubMed ID: 35711445
[TBL] [Abstract][Full Text] [Related]
7. Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study.
Quiroga B; Soler MJ; Ortiz A; Martínez Vaquera S; Jarava Mantecón CJ; Useche G; Sánchez Márquez MG; Carnerero M; Jaldo Rodríguez MT; Muñoz Ramos P; Ruiz San Millán JC; Toapanta N; Gracia-Iguacel C; Aguilar Cervera MC; Balibrea Lara N; Leyva A; Rojas J; Gansevoort RT; de Sequera P;
Nephrol Dial Transplant; 2022 Sep; 37(10):1868-1878. PubMed ID: 34788858
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.
Bensouna I; Caudwell V; Kubab S; Acquaviva S; Pardon A; Vittoz N; Bozman DF; Hanafi L; Faucon AL; Housset P
Am J Kidney Dis; 2022 Feb; 79(2):185-192.e1. PubMed ID: 34508833
[TBL] [Abstract][Full Text] [Related]
9. Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse.
Hsu CM; Weiner DE; Manley HJ; Li NC; Miskulin D; Harford A; Sanders R; Ladik V; Frament J; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
Kidney Med; 2023 Nov; 5(11):100718. PubMed ID: 37786901
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity Rates after SARS-CoV-2 Three-Dose Vaccination in Patients under Dialysis: A Systematic Review and Meta-Analysis.
Yang X; Zhang H; Bao W; Fu S; Jin H
Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560480
[TBL] [Abstract][Full Text] [Related]
11. Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?
Beilhack G; Monteforte R; Frommlet F; Reindl-Schwaighofer R; Strassl R; Vychytil A
Front Med (Lausanne); 2022; 9():905798. PubMed ID: 35814775
[TBL] [Abstract][Full Text] [Related]
12. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort.
Beilhack G; Monteforte R; Frommlet F; Gaggl M; Strassl R; Vychytil A
Front Immunol; 2021; 12():780594. PubMed ID: 34925359
[TBL] [Abstract][Full Text] [Related]
13. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients.
Ohki Y; Kawabe M; Yamamoto I; Katsumata H; Nakada Y; Kobayashi A; Urabe F; Miki J; Yamada H; Kimura T; Matsuo N; Tanno Y; Horino T; Ohkido I; Yamamoto H; Yokoo T
Front Microbiol; 2022; 13():922042. PubMed ID: 35756063
[TBL] [Abstract][Full Text] [Related]
15. Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum.
Quiroga B; Soler MJ; Ortiz A; de Sequera P;
Nefrologia (Engl Ed); 2023; 43(6):676-687. PubMed ID: 37150670
[TBL] [Abstract][Full Text] [Related]
16. Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients.
Einbinder Y; Perl J; Nacasch N; Bnaya A; Shavit L; Erez D; Shashar M; Halperin T; Grupper A; Benchetrit S; Wand O; Cohen-Hagai K
Am J Nephrol; 2022; 53(7):586-590. PubMed ID: 35850101
[TBL] [Abstract][Full Text] [Related]
17. Factors predictive of anti-spike antibody titers after COVID-19 vaccination in hemodialysis patients.
Aoun M; Kahwaji RM; Sleilaty G; Boueri C; Hawi J; Khalil CB; Hage V
Adv Clin Exp Med; 2022 Aug; 31(8):855-861. PubMed ID: 35438849
[TBL] [Abstract][Full Text] [Related]
18. Differences in SARS-CoV-2-Specific Antibody Responses After the First, Second, and Third Doses of BNT162b2 in Naïve and Previously Infected Individuals: A 1-Year Observational Study in Healthcare Professionals.
Ogrič M; Žigon P; Podovšovnik E; Lakota K; Sodin-Semrl S; Rotar Ž; Čučnik S
Front Immunol; 2022; 13():876533. PubMed ID: 35711413
[TBL] [Abstract][Full Text] [Related]
19. Humoral immunity trends in a hemodialysis cohort following SARS-CoV-2 mRNA booster: A cohort study.
Goggins E; Sharma B; Ma JZ; Gautam J; Bowman B
Health Sci Rep; 2024 Feb; 7(2):e1858. PubMed ID: 38357484
[TBL] [Abstract][Full Text] [Related]
20. Humoral Response Following Triple Dose of mRNA Vaccines Against SARS-CoV-2 in Hemodialysis Patients: Results After 1 Year of Follow-Up.
Gallego-Valcarce E; Shabaka A; Leon-Poo M; Gruss E; Acedo-Sanz JM; Cordón A; Cases-Corona C; Fernandez-Juarez G
Front Med (Lausanne); 2022; 9():927546. PubMed ID: 35903310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
